Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(60%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
3
60%
Ph phase_3
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(1)
Other(1)

Detailed Status

Active, not recruiting2
Completed1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

completed120%
active_not_recruiting240%
unknown120%
recruiting120%

Recent Activity

3 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

Cryoablation for the Treatment of Metastatic Cancer

NCT04150939
recruiting

National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group

NCT03978039
completednot_applicable

Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer

NCT03035890
active_not_recruitingnot_applicable

Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy

NCT03835520
unknownphase_3

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

NCT06031597

Clinical Trials (5)

Showing 5 of 5 trials
NCT04150939Not Applicable

Cryoablation for the Treatment of Metastatic Cancer

Active Not Recruiting
NCT03978039

National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group

Recruiting
NCT03035890Not Applicable

Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer

Completed
NCT03835520Not Applicable

Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy

Active Not Recruiting
NCT06031597Phase 3

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5